Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Greffex said it did not use a living or killed virus for its vaccine and instead used an adenovirus-based vector vaccine, which are genetically engineered.
Lead Product(s): COVID-19 vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 12, 2020